Nimesulide:
The Union Government has banned the manufacture, sale and distribution of oral formulations of Nimesulide above 100 mg with immediate effect under Section 26A of the Drugs and Cosmetics Act, 1940.Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of acute pain and fever. It acts by inhibiting chemical mediators responsible for pain and inflammation.
Reason for the ban:
Oral formulations above 100 mg pose a risk to human health, particularly liver-related adverse effects.
Safer alternative analgesics are available in the market.The ban was imposed under Section 26A of the Drugs and Cosmetics Act, 1940, which empowers the government to prohibit drugs harmful to public health.
